Press release from the Competition Council regarding the economic concentration project concerning the joint control acquisition by the investment fund ‘Nama Fund I FPCC RFA’ of the company ‘Acrostak Luxembourg SA’ alongside the historical shareholder ‘Acrostak Corporation (CY) Ltd.’ through the acquisition of 33.8% of its share capital and related voting rights.

In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 issued for its implementation, as amended and supplemented, the Competition Council makes available to the public the ‘operation summary’ below, containing the information provided by the parties.

This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council’s position on the proposed operation.

The publication of this press release does not confirm the completeness of the file as provided for in Article 9 of Decree No. 2-14-652 issued for the implementation of Law No. 104-12 on freedom of prices and competition as amended and supplemented.

Names of the companies and groups involved:

• The acquirer: The investment fund ‘Nama Fund I FPCC RFA’;
• The historical shareholder: the company ‘Acrostak Corporation (CY) Ltd.’;
• The target: The company ‘Acrostak Luxembourg SA’.

Nature of the operation

• Joint control acquisition.

Economic sectors concerned:

• Market for the development and supply of therapeutic catheters.

Deadline for interested third parties to submit their observations:

• 10 days from the date of publication of this press release, i.e. July 14, 2025.

NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES

The Competition Council has received notification of an economic concentration operation concerning the joint control acquisition by the investment fund ‘Nama Fund I FPCC RFA’ of the company ‘Acrostak Luxembourg SA’ alongside the historical shareholder ‘Acrostak Corporation (CY) Ltd.’ through the acquisition of 33.8% of its share capital and related voting rights.

‘Nama Fund I FPCC-RFA’ is a collective investment fund with capital, registered with the Rabat Trade Register under number 185875 and managed by the management company ‘CDG Invest Management SA’ whose registered office is located at Mahaj Ryad Center, Business 7 Building, 3rd floor, Hay Riad, Rabat, Morocco. ‘CDG Invest Management SA’ belongs to the CDG group which is active in 5 main lines of business: savings and pension fund management, territorial development, tourism, investment, banking, and finance.

‘Acrostak Corporation (CY) Ltd.’ is a limited liability company under Cypriot law, registered under number HE 300042, with its registered office at Karaiskaki 28, Kanika Alexander Center, Block 1, 1st floor, Office 113CD, 3032 Limassol, Cyprus. It operates as a holding company.

‘Acrostak Luxembourg SA’ is a public limited company under Luxembourg law, registered with the Trade Register under number B295630, with its registered office at 12C, rue Guillaume J. Kroll, L-1882 Luxembourg. It specializes in holding shares in companies mainly operating in the therapeutic catheter market.

 

Done in Rabat, July 03, 2025